June 10, 2011 · 10:10 AM

France Pulling Diabetic Drug Pioglitazone From Pharmacy Shelves

Bloomberg reported yesterday that the French drug agency is pulling pioglitazone from the market in view of its recent association with bladder cancer.  I mentioned this here May 14.  Pioglitazone is sold in the U.S. as Actos.  I don’t expect the U.S. Food and Drug Administration to follow suit soon.

Steve Parker, M.D.

1 Comment

Filed under Drugs for Diabetes

Tagged as , , ,

One response to “France Pulling Diabetic Drug Pioglitazone From Pharmacy Shelves”

  1. Carol Cavanaugh
    July 15, 2011 at 7:10 AM

    Interesting piece! Actos is a terrible drug that should be banned in the United States, It causes bladder cancer and other serious side effects. This is a great resource:
    http://www.weitzlux.com/actos-cancer_1962929.html